1 Study Coverage
1.1 Small Molecule Targeted Anti-cancer Drug Revenue in Small Molecule Targeted Anti-cancer Drug Business (2017-2022) & (US$ Million) Introduction
1.2 Global Small Molecule Targeted Anti-cancer Drug Outlook 2017 VS 2022 VS 2028
1.2.1 Global Small Molecule Targeted Anti-cancer Drug Market Size for the Year 2017-2028
1.2.2 Global Small Molecule Targeted Anti-cancer Drug Market Size for the Year 2017-2028
1.3 Small Molecule Targeted Anti-cancer Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Small Molecule Targeted Anti-cancer Drug in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Small Molecule Targeted Anti-cancer Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Small Molecule Targeted Anti-cancer Drug Market Dynamics
1.4.1 Small Molecule Targeted Anti-cancer Drug Industry Trends
1.4.2 Small Molecule Targeted Anti-cancer Drug Market Drivers
1.4.3 Small Molecule Targeted Anti-cancer Drug Market Challenges
1.4.4 Small Molecule Targeted Anti-cancer Drug Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Small Molecule Targeted Anti-cancer Drug by Type
2.1 Small Molecule Targeted Anti-cancer Drug Market Segment by Type
2.1.1 EGFR
2.1.2 ALK
2.1.3 Bcr-Abl
2.1.4 Others
2.2 Global Small Molecule Targeted Anti-cancer Drug Market Size by Type (2017, 2022 & 2028)
2.3 Global Small Molecule Targeted Anti-cancer Drug Market Size by Type (2017-2028)
2.4 United States Small Molecule Targeted Anti-cancer Drug Market Size by Type (2017, 2022 & 2028)
2.5 United States Small Molecule Targeted Anti-cancer Drug Market Size by Type (2017-2028)
3 Small Molecule Targeted Anti-cancer Drug by Application
3.1 Small Molecule Targeted Anti-cancer Drug Market Segment by Application
3.1.1 Liver Cancer
3.1.2 Colorectal Cancer
3.1.3 Lung Cancer
3.1.4 Gastric Cancer
3.1.5 Breast Cancer
3.1.6 Esophageal Cancer
3.1.7 Others
3.2 Global Small Molecule Targeted Anti-cancer Drug Market Size by Application (2017, 2022 & 2028)
3.3 Global Small Molecule Targeted Anti-cancer Drug Market Size by Application (2017-2028)
3.4 United States Small Molecule Targeted Anti-cancer Drug Market Size by Application (2017, 2022 & 2028)
3.5 United States Small Molecule Targeted Anti-cancer Drug Market Size by Application (2017-2028)
4 Global Small Molecule Targeted Anti-cancer Drug Competitor Landscape by Company
4.1 Global Small Molecule Targeted Anti-cancer Drug Market Size by Company
4.1.1 Top Global Small Molecule Targeted Anti-cancer Drug Companies Ranked by Revenue (2021)
4.1.2 Global Small Molecule Targeted Anti-cancer Drug Revenue by Player (2017-2022)
4.2 Global Small Molecule Targeted Anti-cancer Drug Concentration Ratio (CR)
4.2.1 Small Molecule Targeted Anti-cancer Drug Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Small Molecule Targeted Anti-cancer Drug in 2021
4.2.3 Global Small Molecule Targeted Anti-cancer Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Small Molecule Targeted Anti-cancer Drug Headquarters, Revenue in Small Molecule Targeted Anti-cancer Drug Business (2017-2022) & (US$ Million) Type
4.3.1 Global Small Molecule Targeted Anti-cancer Drug Headquarters and Area Served
4.3.2 Global Small Molecule Targeted Anti-cancer Drug Companies Revenue in Small Molecule Targeted Anti-cancer Drug Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Small Molecule Targeted Anti-cancer Drug Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Small Molecule Targeted Anti-cancer Drug Market Size by Company
4.5.1 Top Small Molecule Targeted Anti-cancer Drug Players in United States, Ranked by Revenue (2021)
4.5.2 United States Small Molecule Targeted Anti-cancer Drug Revenue by Players (2020, 2021 & 2022)
5 Global Small Molecule Targeted Anti-cancer Drug Market Size by Region
5.1 Global Small Molecule Targeted Anti-cancer Drug Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Small Molecule Targeted Anti-cancer Drug Market Size by Region (2017-2028)
5.2.1 Global Small Molecule Targeted Anti-cancer Drug Market Size by Region: 2017-2022
5.2.2 Global Small Molecule Targeted Anti-cancer Drug Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Small Molecule Targeted Anti-cancer Drug Market Size YoY Growth 2017-2028
6.1.2 North America Small Molecule Targeted Anti-cancer Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Small Molecule Targeted Anti-cancer Drug Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Small Molecule Targeted Anti-cancer Drug Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Small Molecule Targeted Anti-cancer Drug Market Size YoY Growth 2017-2028
6.3.2 Europe Small Molecule Targeted Anti-cancer Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Small Molecule Targeted Anti-cancer Drug Market Size YoY Growth 2017-2028
6.4.2 Latin America Small Molecule Targeted Anti-cancer Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Small Molecule Targeted Anti-cancer Drug Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Small Molecule Targeted Anti-cancer Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Astrazeneca
7.1.1 Astrazeneca Company Details
7.1.2 Astrazeneca Business Overview
7.1.3 Astrazeneca Small Molecule Targeted Anti-cancer Drug Introduction
7.1.4 Astrazeneca Revenue in Small Molecule Targeted Anti-cancer Drug Business (2017-2022)
7.1.5 Astrazeneca Recent Development
7.2 Novartis
7.2.1 Novartis Company Details
7.2.2 Novartis Business Overview
7.2.3 Novartis Small Molecule Targeted Anti-cancer Drug Introduction
7.2.4 Novartis Revenue in Small Molecule Targeted Anti-cancer Drug Business (2017-2022)
7.2.5 Novartis Recent Development
7.3 Millennium Pharmaceuticals
7.3.1 Millennium Pharmaceuticals Company Details
7.3.2 Millennium Pharmaceuticals Business Overview
7.3.3 Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug Introduction
7.3.4 Millennium Pharmaceuticals Revenue in Small Molecule Targeted Anti-cancer Drug Business (2017-2022)
7.3.5 Millennium Pharmaceuticals Recent Development
7.4 Bayer
7.4.1 Bayer Company Details
7.4.2 Bayer Business Overview
7.4.3 Bayer Small Molecule Targeted Anti-cancer Drug Introduction
7.4.4 Bayer Revenue in Small Molecule Targeted Anti-cancer Drug Business (2017-2022)
7.4.5 Bayer Recent Development
7.5 Exelixis
7.5.1 Exelixis Company Details
7.5.2 Exelixis Business Overview
7.5.3 Exelixis Small Molecule Targeted Anti-cancer Drug Introduction
7.5.4 Exelixis Revenue in Small Molecule Targeted Anti-cancer Drug Business (2017-2022)
7.5.5 Exelixis Recent Development
7.6 Abbvie
7.6.1 Abbvie Company Details
7.6.2 Abbvie Business Overview
7.6.3 Abbvie Small Molecule Targeted Anti-cancer Drug Introduction
7.6.4 Abbvie Revenue in Small Molecule Targeted Anti-cancer Drug Business (2017-2022)
7.6.5 Abbvie Recent Development
7.7 Boehringer-Ingelheim
7.7.1 Boehringer-Ingelheim Company Details
7.7.2 Boehringer-Ingelheim Business Overview
7.7.3 Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug Introduction
7.7.4 Boehringer-Ingelheim Revenue in Small Molecule Targeted Anti-cancer Drug Business (2017-2022)
7.7.5 Boehringer-Ingelheim Recent Development
7.8 Eisai
7.8.1 Eisai Company Details
7.8.2 Eisai Business Overview
7.8.3 Eisai Small Molecule Targeted Anti-cancer Drug Introduction
7.8.4 Eisai Revenue in Small Molecule Targeted Anti-cancer Drug Business (2017-2022)
7.8.5 Eisai Recent Development
7.9 Pfizer
7.9.1 Pfizer Company Details
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Small Molecule Targeted Anti-cancer Drug Introduction
7.9.4 Pfizer Revenue in Small Molecule Targeted Anti-cancer Drug Business (2017-2022)
7.9.5 Pfizer Recent Development
7.10 Bristol-Myers Squibb
7.10.1 Bristol-Myers Squibb Company Details
7.10.2 Bristol-Myers Squibb Business Overview
7.10.3 Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug Introduction
7.10.4 Bristol-Myers Squibb Revenue in Small Molecule Targeted Anti-cancer Drug Business (2017-2022)
7.10.5 Bristol-Myers Squibb Recent Development
7.11 Roche
7.11.1 Roche Company Details
7.11.2 Roche Business Overview
7.11.3 Roche Small Molecule Targeted Anti-cancer Drug Introduction
7.11.4 Roche Revenue in Small Molecule Targeted Anti-cancer Drug Business (2017-2022)
7.11.5 Roche Recent Development
7.12 Bettapharma
7.12.1 Bettapharma Company Details
7.12.2 Bettapharma Business Overview
7.12.3 Bettapharma Small Molecule Targeted Anti-cancer Drug Introduction
7.12.4 Bettapharma Revenue in Small Molecule Targeted Anti-cancer Drug Business (2017-2022)
7.12.5 Bettapharma Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
